Quarterly report pursuant to Section 13 or 15(d)

Organization and Description of Business (Narrative) (Details)

v3.21.2
Organization and Description of Business (Narrative) (Details) - Caelum [Member] - AstraZeneca [Member] - Subsequent Events [Member]
$ in Millions
Oct. 06, 2021
USD ($)
Deconsolidation of consolidated partner company, percentage deconsolidated 100.00%
Deconsolidation of consolidated partner company, upfront payment $ 150
Deconsolidation of consolidated partner company, contingent payment 350
Maximum [Member]  
Deconsolidation of consolidated partner company, contingent payment $ 350